PeterM.AndersonMDPhD

Pediatric Hematology & Oncology • Cleveland, OH

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Staff Physician

Join to view full profile

Dr. Anderson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anderson's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland Clinic Pediatric Heme/Onc/BMT R3
Cleveland, OH 44195
Phone+1 216-308-2706

Fax+1 216-444-3577

Summary

Dr. Peter Anderson is a pediatric hematologist/oncologist in Cleveland, OH and is affiliated with multiple hospitals in the area, including Cleveland Clinic and Cleveland Clinic Children's. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 36 years. He specializes in pediatric sarcoma oncology and pediatric solid tumor oncology and is experienced in pediatric oncology- solid tumors.

Education & Training

University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1985 - 1988
Duke University HospitalResidency, Pediatrics, 1983 - 1985
Duke University HospitalResidency, Internal Medicine, 1981 - 1983
Icahn School of Medicine at Mount SinaiClass of 1981

Certifications & Licensure

AZ State Medical License 2002 - 2026
CA State Medical License 2024 - 2026
IA State Medical License 2015 - 2026
IL State Medical License 2024 - 2026
TN State Medical License 2024 - 2026
TX State Medical License 2006 - 2026
CO State Medical License 2024 - 2025
MN State Medical License 1985 - 2025
NC State Medical License 2013 - 2025
NV State Medical License 2024 - 2025
OH State Medical License 2015 - 2025
WI State Medical License 1985 - 2025
PA State Medical License 2023 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Join now to see all

Awards, Honors, & Recognition

Professor Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Professor University of Texas MD Anderson CancerCenter, 2005
Top Doctors:SE Texas Castle Connolly, 2013

Clinical Trials

Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma Start of enrollment: 2008 Jan 01
Completed
Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy Start of enrollment: 2008 May 01
Terminated
Not Applicable
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma Start of enrollment: 2016 Aug 01
Terminated
Phase 1, Phase 2
Phase 2 Study of ONC201 in Neuroendocrine Tumors Start of enrollment: 2017 Aug 02
Completed
Phase 2
A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide Start of enrollment: 2018 Aug 21
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma.
Eashwar Somasundaram, Peter M Anderson, Timothy D Smile, Ahmed Halima, James B Broughman
Scientific Reports. 2023-11-07
Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report.
David S Buchberger, Samantha K Cook, Peter M Anderson, Dale R Shepard, Jamie A Ku
Pediatric Blood & Cancer. 2023-10-01
5 citations
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA.
Peter Anderson, Maurizio Ghisoli, Brian D Crompton, Kelly S Klega, Leonard H Wexler
Clinical Cancer Research. 2023-05-01

Lectures

Virtual visits for children, adolescents, and young adults with cancer.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

'Always Keep Your Hope': Cleveland Heights Woman Names Son After Oncologist Who Helped Save Her LifeMay 25th, 2022
Len Rome’s Local Health: Childhood Cancer Patient Finds Hope and Treatment in Northeast OhioOctober 1st, 2020
Young Girl Is Cancer-Free After Yearlong Battle with Rare SarcomaSeptember 24th, 2020
Join now to see all

Grant Support

153 Sm-Edtmp For Bone Metastases--Phase I Dose Escalation StudyNational Center For Research Resources1998–2002
IL-2 Liposomes In Cancer Of The LungNational Cancer Institute1991–1995

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
ASPHO
Member
SIOP
Member
Alpha Omega Alpha Honor Medical Society - AOA
Member
CTOS
Member
American Society of Hematology - ASH
Member

Industry Relationships

Inventor, Healiosglutamine+ disaccharide (trehalose) to reduce mucositis (stomatitis, esophagitis, enteritis)Disclosure: Enlivity Scientific Advisory Board2015 - Present